Discover the complete record of transactions filed by Gosebruch Henry O, Director. Officer active across 1 companies, notably AbbVie Inc.. Cumulatively, 8 filings have been recorded. Total volume traded: €4.1m. The latest transaction was filed on 1 March 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Henry O. Gosebruch is EVP and Chief Strategy Officer at AbbVie Inc. He oversees the company's strategy and contributes to strategic planning. His role is essential in ensuring growth and innovation at AbbVie.